Biochemical detection of left-ventricular systolic dysfunction
- 3 January 1998
- journal article
- Published by Elsevier BV in The Lancet
- Vol. 351 (9095), 9-13
- https://doi.org/10.1016/s0140-6736(97)03034-1
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- Symptomatic and asymptomatic left-ventricular systolic dysfunction in an urban populationThe Lancet, 1997
- Plasma cardiac natriuretic peptide determination as a screening test for the detection of patients with mild left ventricular impairment.Heart, 1996
- The relative value of the natriuretic peptides as markers for detecting abnormal ventricular structure and functionJournal of the American College of Cardiology, 1996
- Detection of left ventricular dysfunction after acute myocardial infarction: comparison of clinical, echocardiographic, and neurohormonal methods.Heart, 1994
- Plasma brain natriuretic peptide in assessment of acute dyspnoeaThe Lancet, 1994
- Plasma brain natriuretic peptide as an indicator for angiotensin-converting-enzyme inhibition after myocardial infarctionThe Lancet, 1993
- Circulating N-terminal atrial natriuretic peptide as a marker for symptomless left-ventricular dysfunctionThe Lancet, 1993
- Effect of Enalapril on Survival in Patients with Reduced Left Ventricular Ejection Fractions and Congestive Heart FailureThe New England Journal of Medicine, 1991
- Effects of Enalapril on Mortality in Severe Congestive Heart FailureThe New England Journal of Medicine, 1987
- Left ventricular volume from paired biplane two-dimensional echocardiography.Circulation, 1979